Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Hantech Bio-Technology Co., Ltd. (1294) Financial Statements

Hantech Bio-Technology Co., Ltd. Financial Overview

Hantech Bio-Technology Co., Ltd.'s market cap is currently NT$1.62B. The company's EPS TTM is NT$4.31; its P/E ratio is 11.43; and it has a dividend yield of 6.70%. Hantech Bio-Technology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total RevenueNT$ 778.54MNT$ 748.42MNT$ 625.14MNT$ 302.52MNT$ 240.29M
Gross ProfitNT$ 283.81MNT$ 305.74MNT$ 280.85MNT$ 126.63MNT$ 101.03M
Operating IncomeNT$ 172.98MNT$ 197.44MNT$ 185.71MNT$ 59.80MNT$ 38.91M
EBITDANT$ 211.15MNT$ 232.09MNT$ 206.65MNT$ 78.52MNT$ 58.67M
Net IncomeNT$ 139.08MNT$ 155.67MNT$ 148.12MNT$ 47.47MNT$ 32.56M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 339.38MNT$ 382.42MNT$ 167.09MNT$ 75.04MNT$ 86.41M
Total AssetsNT$ 1.17BNT$ 1.12BNT$ 930.94MNT$ 473.59MNT$ 375.65M
Total DebtNT$ 113.28MNT$ 107.61MNT$ 307.09MNT$ 112.89MNT$ 139.68M
Net DebtNT$ -205.42MNT$ -274.81MNT$ 140.00MNT$ 37.85MNT$ 53.27M
Total LiabilitiesNT$ 334.10MNT$ 298.18MNT$ 529.56MNT$ 205.02MNT$ 197.74M
Stockholders' EquityNT$ 829.16MNT$ 817.78MNT$ 398.09MNT$ 266.89MNT$ 174.62M
Cash Flow
Free Cash FlowNT$ 145.19MNT$ 125.36MNT$ -105.31MNT$ -20.44MNT$ -35.93M
Operating Cash FlowNT$ 160.63MNT$ 150.75MNT$ 191.91MNT$ 63.18MNT$ 44.39M
Investing Cash FlowNT$ -107.40MNT$ -25.38MNT$ -295.63MNT$ -84.07MNT$ -79.76M
Financing Cash FlowNT$ -186.28MNT$ 89.75MNT$ 195.83MNT$ 9.52MNT$ 40.40M

Currency in TWD

Hantech Bio-Technology Co., Ltd. Earnings and Revenue History

0300M600M900M0 %10 %20 %30 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Hantech Bio-Technology Co., Ltd. Liabilities to Assets

0500M1B1.5B24 %36 %48 %60 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Hantech Bio-Technology Co., Ltd. Cash Flow

-400M-300M-200M-100M0100M200M300M20182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Hantech Bio-Technology Co., Ltd. Forecast EPS vs Actual EPS

0.40.60.811.21.4Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >